SoloHealth named to Georgia’s list of Top 10 Innovative Technology Companies
ATLANTA — SoloHealth on Thursday announced it has been selected as one of the Technology Association of Georgia’s Top 10 Innovative Technology Companies. SoloHealth was recognized for its FDA-approved health and wellness kiosk, the SoloHealth Station.
"The Top 10 awards are given to an elite group of companies whose products and solutions are not only changing their respective industries, they also are putting Georgia on the map as a state where technology innovation can thrive," stated Tino Mantella, president & CEO of TAG.
"We are honored and humbled to be recognized with this group of incredibly talented and innovative companies, as well as by a worthy organization like TAG,” commented Bart Foster, CEO SoloHealth. “We are extremely bullish on our product, people and technology, and we look forward to what we expect will be our most pivotal year in terms of scale and expansion into exciting new health services opportunities," he said. "We are exploring many new ways we can leverage our versatile platform to continue to help better our nation’s health, especially as the country prepares for the Affordable Care Act rollout.”
Projected to be in more than 3,500 locations by end of year, the SoloHealth Station is currently in select retailers across America, including Walmart, Sam’s Club, Safeway and Schnuck’s Markets. The SoloHealth Station is a healthcare access platform for consumers, providing screenings for vision, blood pressure, weight and body mass index, a symptom checker as well as an overall health assessment free of charge. The Station also connects consumers to local professionals through their databases and can serve as a resource to provide health and wellness information and services.
Merck’s James Mackey elected CHPA chairman
NAPLES, Fla. — The Consumer Healthcare Products Association on Wednesday officially elected James Mackey, SVP U.S. region head for Merck Consumer Care, as the association’s chairman. Paul Sturman, president and general manager Pfizer Consumer Healthcare, will serve as immediate past chairman.
"CHPA is indebted to Paul Sturman for his leadership and vision as chair of our industry association these past two years," stated CHPA president and CEO Scott Melville. "During his chairmanship, our industry became a better advocate for self-care and its contribution to U.S. healthcare," he said. "We’re fortunate to have someone like Jim Mackey stepping up to continue this positive momentum. Jim’s industry experience and longtime involvement with CHPA have earned him the respect of fellow board members and will ensure a seamless transition of leadership."
For the full list of current CHPA board members, click here.
Get connected and follow us on LinkedIn for the most in-depth coverage of drug store news. Join the conversation.
Retailer taken to task for iterating supplement claim found on NIH information page
BAKERSFIELD, Calif. — Walgreens was singled out in a lawsuit earlier this week here for suggesting a vitamin E supplement may help improve cardiovascular health.
Specifically, according to a Reuters report Monday, the complainant stated that Walgreens’ Vitamin E 400 IU purported to "naturally contribute to cardiovascular health by helping to protect LDL cholesterol from oxidation which may cause cellular damage."
The plaintiff may have an uphill battle, however. According to the National Institute of Health’s Office of Dietary Supplements, vitamin E has been shown to do exactly that.
"Evidence that vitamin E could help prevent or delay coronary heart disease comes from several sources," the government agency notes on its Dietary Supplement Fact Sheet on vitamin E for health professionals. "In vitro studies have found that the nutrient inhibits oxidation of low-density lipoprotein cholesterol, thought to be a crucial initiating step for atherosclerosis [hardening of the arteries]. Vitamin E might also help prevent the formation of blood clots that could lead to a heart attack or venous thromboembolism."
Like this story? Find us on Facebook for more insight, analysis and the latest in drug store news. Join the conversation.